Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies.

Abstract:

:Central nervous system (CNS) recurrence continues to be a significant complication in the treatment of adult patients with acute lymphoblastic leukemia (ALL). Preventing CNS recurrence has been a therapeutic challenge and has not been addressed critically in many clinical trials. Adult studies modeled on childhood ALL studies have used multiple treatment modalities, including radiation therapy, systemic therapy, intrathecal therapy, and combinations thereof. Cranial irradiation is effective but is offset by substantial toxicity, including neurologic sequelae. Systemic chemotherapy, especially with cytarabine (AraC) and methotrexate, has demonstrated promise in decreasing CNS recurrence, but therapeutic levels of drugs in the cerebrospinal fluid (CSF) are not maintained. Intrathecal chemotherapy with or without high-dose systemic therapy is the most common approach to CNS prophylaxis. Liposomal AraC recently has become available and confers prolonged levels of free AraC in the CSF, a critical requirement for CNS prophylactic therapy. This review discusses the various modalities used for CNS prophylaxis in patients with ALL and the emerging trends, with specific emphasis on the outcome in terms of event-free survival and toxicity.

journal_name

Cancer

journal_title

Cancer

authors

Jabbour E,Thomas D,Cortes J,Kantarjian HM,O'Brien S

doi

10.1002/cncr.25008

subject

Has Abstract

pub_date

2010-05-15 00:00:00

pages

2290-300

issue

10

eissn

0008-543X

issn

1097-0142

journal_volume

116

pub_type

杂志文章,评审

相关文献

CANCER文献大全
  • Influenza in children and young adults with cancer: 20 cases.

    abstract::The purpose of this study was to characterize the clinical features of laboratory-confirmed influenza in 20 children and young adults with cancer who were receiving immunosuppressive therapy. Viruses isolated from pharyngeal and nasopharyngeal cultures were identified as the A/Hong Kong/1/68 strain or one of its varia...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197701)39:1<350::aid-cncr2820390

    authors: Feldman S,Webster RG,Sugg M

    更新日期:1977-01-01 00:00:00

  • Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.

    abstract:BACKGROUND:Acute myeloid leukemia (AML) with t(6;11)(q27;q23) is a well established but rare entity, and few studies have reported the full clinical, hematologic, and outcome data of patients with this disease. METHODS:To characterize the features of t(6;11) AML, the authors searched the Cancer and Leukemia Group B (C...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.20489

    authors: Blum W,Mrózek K,Ruppert AS,Carroll AJ,Rao KW,Pettenati MJ,Anastasi J,Larson RA,Bloomfield CD

    更新日期:2004-09-15 00:00:00

  • Patterns of care for women with cervical cancer in the United States.

    abstract:BACKGROUND:Recommendations for pretreatment evaluation and treatment of cervical cancer have significantly evolved over the last decade because of the results of multiple randomized studies comparing the addition of platin-based chemoradiation as well as the widespread dissemination and use of imaging modalities. This ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23682

    authors: Trimble EL,Harlan LC,Gius D,Stevens J,Schwartz SM

    更新日期:2008-08-15 00:00:00

  • Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis.

    abstract::Myelofibrosis occurs in various hematologic neoplasias, including myelodysplastic syndrome (MDS), with a relatively low incidence. To gain insight into the clinical and cytogenetic implications of MDS patients in whom myelofibrosis develops, statistical analysis was done on 82 primary MDS patients with successful cyto...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910701)68:1<178::aid-cncr28206

    authors: Ohyashiki K,Sasao I,Ohyashiki JH,Murakami T,Iwabuchi A,Tauchi T,Saito M,Nakazawa S,Serizawa H,Ebihara Y

    更新日期:1991-07-01 00:00:00

  • Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.

    abstract:BACKGROUND:The association of community factors and outcomes after hematopoietic cell transplantation (HCT) has not been comprehensively described. Using the County Health Rankings and Roadmaps (CHRR) and the Center for International Blood and Marrow Transplant Research (CIBMTR), this study evaluated the impact of comm...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33232

    authors: Hong S,Brazauskas R,Hebert KM,Ganguly S,Abdel-Azim H,Diaz MA,Beattie S,Ciurea SO,Szwajcer D,Badawy SM,Gratwohl AA,LeMaistre C,Aljurf MDSM,Olsson RF,Bhatt NS,Farhadfar N,Yared JA,Yoshimi A,Seo S,Gergis U,Beitinjane

    更新日期:2021-02-15 00:00:00

  • Adenocarcinoma in situ of the cervix.

    abstract:BACKGROUND:The current study examines 1) the sensitivity of detection and 2) sampling and screening/diagnostic error in the cytologic diagnosis of adenocarcinoma in situ (AIS) of the cervix. The data were taken from public and private sector screening laboratories reporting 25,000 and 80,000 smears, respectively, each ...

    journal_title:Cancer

    pub_type: 评论,杂志文章

    doi:10.1002/cncr.10886

    authors: Schoolland M,Segal A,Allpress S,Miranda A,Frost FA,Sterrett GF

    更新日期:2002-12-25 00:00:00

  • Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden.

    abstract:BACKGROUND:Pathologically, benign prostatic hyperplasia (BPH) is not considered a precursor for prostate carcinoma. However, because the two conditions share not only a similar hormonal environment within the prostate but also several common risk factors, it is possible that men with BPH may be at increased risk of pro...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11710

    authors: Chokkalingam AP,Nyrén O,Johansson JE,Gridley G,McLaughlin JK,Adami HO,Hsing AW

    更新日期:2003-10-15 00:00:00

  • Anterior chemotherapy in esophageal cancer.

    abstract::Front loading chemotherapy using methotrexate (200 mg/m2) alone or methotrexate (200 mg/m2) with cisplatin (20 mg/m2 daily for 5 days) was used in epidermoid carcinoma of esophagus. Evaluation after two courses showed objective response of 50% or greater in 48% of patients with methotrexate alone. Response rate was in...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19851001)56:7<1502::aid-cncr2820

    authors: Advani SH,Saikia TK,Swaroop S,Ramakrishnan G,Nair CN,Dinshaw KA,Sharma S,Vyas JJ,Desai PB

    更新日期:1985-10-01 00:00:00

  • Transurethral resection of the prostate and metastatic prostate cancer.

    abstract::Demonstration of malignant cells in blood specimens collected during transurethral resection of the prostate (TURP) has implicated TURP in the dissemination of prostatic cancer. Of 153 patients who underwent radiation therapy for prostate cancer between January 1977 and June 1990 and were retrospectively analyzed, 93 ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19911101)68:9<1895::aid-cncr2820

    authors: Pansadoro V,Sternberg CN,DePaula F,Florio A,Giannarelli D,Arcangeli G

    更新日期:1991-11-01 00:00:00

  • Type Ia glycogenosis associated with hepatocellular carcinoma.

    abstract::The predisposition of preexisting cirrhotic metabolic liver disease to the development of hepatocellular carcinoma is well established. However, the association between glycogenoses (a form of noncirrhotic metabolic liver disease) and the formation of benign and malignant liver tumors is less well known. The sixth cas...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19920315)69:6<1320::aid-cncr2820

    authors: Conti JA,Kemeny N

    更新日期:1992-03-15 00:00:00

  • Myeloproliferative disorder with unusual marrow chromosome constitution.

    abstract::This report describes a patient referred at 14 years in 1971, after one year's surveillance by the family physician, for a persistently elevated erythrocyte sedimentation rate, leukopenia, and relative lymphocytosis. Despite the documented myeloproliferative syndrome of seven years, significant physiologic impairment ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810901)48:5<1164::aid-cncr2820

    authors: Whaun JM,Lin CC,Biederman B,Cornish SJ,Dundas JB

    更新日期:1981-09-01 00:00:00

  • Transformation of Hodgkin's disease into malignant fibrous histiocytoma.

    abstract::The continuity that exists between Hodgkin's disease and the fibrohistiocytoses has only recently been recognized. Four cases are presented that illustrate this phenomenon. The fibrohistiocytic component of the Hodgkin's lesion may lag behind the lymphoreticular component, may be present in equal proportion, or may as...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860115)57:2<264::aid-cncr28205

    authors: Suster S

    更新日期:1986-01-15 00:00:00

  • Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose.

    abstract:BACKGROUND:In a cohort including 5112 prostate cancer (pCa) patients, the authors investigated associations among triglycerides (TG), total cholesterol (TC), and pCa while taking into account glucose. METHODS:A cohort (n = 200,660) based on 4 groups of men, according to age at cohort entry, with TG, TC, and glucose me...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25758

    authors: Van Hemelrijck M,Garmo H,Holmberg L,Walldius G,Jungner I,Hammar N,Lambe M

    更新日期:2011-05-15 00:00:00

  • Costs of cancer along the care continuum: What we can expect based on recent literature.

    abstract:BACKGROUND:Cancer costs should be discussed by patients and providers, but information is not readily available. Results from recently published studies (in the last 5 years) on direct and indirect cancer costs may help guide these discussions. METHODS:The authors reviewed studies published between 2013 and 2017 that ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.31643

    authors: Pisu M,Henrikson NB,Banegas MP,Yabroff KR

    更新日期:2018-11-01 00:00:00

  • A study of 15 cases of primary mediastinal lymphoma of B-cell type.

    abstract::Fifteen cases of pure supradiapragmatic lymphoma with initial prominent antero-superior mediastinal involvement displaying a B-cell pattern of reactivity were studied. These cases occurred in six men and nine women with a median age of 33 years at diagnosis (range, 23 to 75 years). Supradiapragmatic peripheral lymphad...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920515)69:10<2561::aid-cncr282

    authors: Lavabre-Bertrand T,Donadio D,Fegueux N,Jessueld D,Taib J,Charlier D,Rousset T,Emberger JM,Baldet P,Navarro M

    更新日期:1992-05-15 00:00:00

  • Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma.

    abstract:BACKGROUND:Significant antitumor effects were previously observed with radioimmunotherapy (RIT) using an anti-carcinoembryonic antigen (CEA) monoclonal antibody (F6) labeled with iodine-131 in medullary thyroid cancer (MTC)-bearing nude mice. Nevertheless, no complete response was achieved. Because angiogenesis is crit...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24792

    authors: Salaun PY,Bodet-Milin C,Frampas E,Oudoux A,Saï-Maurel C,Faivre-Chauvet A,Barbet J,Paris F,Kraeber-Bodéré F

    更新日期:2010-02-15 00:00:00

  • Clinical evaluation of specific gamma-GTP isoenzyme in patients with hepatocellular carcinoma.

    abstract::The authors evaluated specific gamma-GTP isoenzyme (specific gamma-GTP) found in sera of patients with hepatocellular carcinoma (HCC). In addition to band II and II' which had been reported in our previous publication, band I' also had a high specificity for HCC. One or more of these bands were detectable in 109 (55%)...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830115)51:2<327::aid-cncr28205

    authors: Sawabu N,Nakagen M,Ozaki K,Wakabayashi T,Toya D,Hattori N,Ishii M

    更新日期:1983-01-15 00:00:00

  • The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer.

    abstract:BACKGROUND:The association of increasing radiotherapy (RT) dose with reduced biochemical failure (BF) is accepted widely. However, there is little direct evidence that dose escalation has an impact on distant metastasis (DM) or overall mortality (OM). These associations were examined in the current study. METHODS:The ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11927

    authors: Jacob R,Hanlon AL,Horwitz EM,Movsas B,Uzzo RG,Pollack A

    更新日期:2004-02-01 00:00:00

  • Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium.

    abstract:BACKGROUND:The unknown etiology of endometrioid carcinomas of the ovary and the relatively high frequency of a concomitant carcinoma of the endometrium in these patients warrants study of such tumors. The aim of this study was to identify the genetic alterations involved in endometrioid ovarian cancer development, and ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950815)76:4<650::aid-cncr28207

    authors: Shenson DL,Gallion HH,Powell DE,Pieretti M

    更新日期:1995-08-15 00:00:00

  • Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report.

    abstract::Plasminogen activator is a serine protease which exists in two forms, known as tissue-type plasminogen activator and urokinase-type plasminogen activator. Here, we show that urokinase-type plasminogen activator activity in primary breast carcinomas correlates with both size of tumor and number of axillary nodes with m...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880801)62:3<531::aid-cncr28206

    authors: Duffy MJ,O'Grady P,Devaney D,O'Siorain L,Fennelly JJ,Lijnen HJ

    更新日期:1988-08-01 00:00:00

  • Spontaneously regressing adrenocortical carcinoma in a newborn. A case report with DNA ploidy analysis.

    abstract::Adrenal cortical carcinoma is an uncommon neoplasm in children. Only a handful of congenital adrenal cortical carcinoma cases have been described. A newborn who had metastatic adrenal cortical carcinoma (skin metastases and cerebral lesions) is described. This patient underwent surgical resection of the right adrenal ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880801)62:3<507::aid-cncr28206

    authors: Saracco S,Abramowsky C,Taylor S,Silverman RA,Berman BW

    更新日期:1988-08-01 00:00:00

  • Heparanase up-regulation in tongue cancer: tissue and saliva analysis.

    abstract:BACKGROUND:Heparanase up-regulation has been correlated with reduced postoperative survival in various cancers. METHODS:Heparanase expression was analyzed in 60 consenting tongue (mobile) cancer patients by means of immunohistochemistry. Heparanase levels were also analyzed in the saliva of both healthy controls and t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23095

    authors: Nagler R,Ben-Izhak O,Cohen-Kaplan V,Shafat I,Vlodavsky I,Akrish S,Ilan N

    更新日期:2007-12-15 00:00:00

  • Pathologic classification of prostate carcinoma: the impact of margin status.

    abstract:BACKGROUND:A proposed pathologic (pTNM) classification system for prostate carcinoma was analyzed for its impact on survival outcome in the prostate specific antigen (PSA) era. The impact of margin status on the survival outcome of patients with otherwise organ-confined disease (i.e., without extraprostatic extension o...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19980301)82:5<902::aid-cnc

    authors: Blute ML,Bostwick DG,Seay TM,Martin SK,Slezak JM,Bergstralh EJ,Zincke H

    更新日期:1998-03-01 00:00:00

  • Causes of death after breast cancer diagnosis: A US population-based analysis.

    abstract:BACKGROUND:The focus on noncancer causes of death in patients with breast cancer (BC) remains superficial. The objective of the current study was to assess and quantify causes of death after BC diagnosis. METHODS:In total, 754,270 women with BC in the United States who were diagnosed during 2000 through 2015 and retri...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32648

    authors: Afifi AM,Saad AM,Al-Husseini MJ,Elmehrath AO,Northfelt DW,Sonbol MB

    更新日期:2020-04-01 00:00:00

  • Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions.

    abstract:BACKGROUND:The authors evaluated the role of 5-aminolevulinic acid (5-ALA)-induced fluorescence endoscopy (AFE) in the detection of flat urothelial lesions in light of the suggestions made for flat neoplastic lesions within the 1999 World Health Organization (WHO) classification of urinary bladder tumors. METHODS:From...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10821

    authors: Zaak D,Hungerhuber E,Schneede P,Stepp H,Frimberger D,Corvin S,Schmeller N,Kriegmair M,Hofstetter A,Knuechel R

    更新日期:2002-09-15 00:00:00

  • A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer.

    abstract::Tumor cell DNA (ploidy) content was measured prospectively in samples from 320 patients resected for colorectal cancer with a minimum follow-up time of 2 years. All patients were followed and those with recurrence were investigated carefully. There was no correlation between tumors with an abnormal cellular DNA conten...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910515)67:10<2599::aid-cncr282

    authors: Armitage NC,Ballantyne KC,Sheffield JP,Clarke P,Evans DF,Hardcastle JD

    更新日期:1991-05-15 00:00:00

  • Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials.

    abstract:BACKGROUND:The authors investigated the putative surrogate endpoints of best response, complete response (CR), confirmed response, and progression-free survival (PFS) for associations with overall survival (OS), and as possible surrogate endpoints for OS. METHODS:Individual patient data from 870 untreated extensive st...

    journal_title:Cancer

    pub_type: 杂志文章,meta分析

    doi:10.1002/cncr.25526

    authors: Foster NR,Qi Y,Shi Q,Krook JE,Kugler JW,Jett JR,Molina JR,Schild SE,Adjei AA,Mandrekar SJ

    更新日期:2011-03-15 00:00:00

  • Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial.

    abstract::The German Society of Pediatric Oncology in 1981 initiated the Cooperative Ewing's Sarcoma Study (CESS 81) using a four-drug combination of chemotherapy prior to definitive local control with surgery and/or radiation. From January 1, 1981 until February 28, 1985, 93 patients were registered at the trial office from 54...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880101)61:1<23::aid-cncr282061

    authors: Jürgens H,Exner U,Gadner H,Harms D,Michaelis J,Sauer R,Treuner J,Voûte T,Winkelmann W,Winkler K

    更新日期:1988-01-01 00:00:00

  • A compound follicular-parafollicular cell carcinoma of the thyroid: a new tumor entity?

    abstract::An unusual thyroid carcinoma is described, showing structural, histochemical and radioimmunologic features of both a follicular and a parafollicular cell carcinoma. Radioimmunoassay revealed high levels of thyroglobulin in the patient's serum and in extracts from metastatic tumor tissue. Immunoreactive thyroglobulin w...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830915)52:6<1053::aid-cncr2820

    authors: Ljungberg O,Ericsson UB,Bondeson L,Thorell J

    更新日期:1983-09-15 00:00:00

  • Treatment of recurrent epithelial ovarian cancer.

    abstract::The majority of patients with advanced ovarian cancer progress after first-line therapy and require further treatment. Tumor biology, prior chemotherapy, responses to previous therapy, performance status, and toxicity are the characteristics that influence treatment choice. These criteria have been linked to the time ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.32500

    authors: Pignata S,Pisano C,Di Napoli M,Cecere SC,Tambaro R,Attademo L

    更新日期:2019-12-15 00:00:00